floxuridine has been researched along with Adjuvant Arthritis in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boot, EP | 1 |
| Koning, GA | 1 |
| Storm, G | 1 |
| Wagenaar-Hilbers, JP | 1 |
| van Eden, W | 1 |
| Everse, LA | 1 |
| Wauben, MH | 1 |
1 other study available for floxuridine and Adjuvant Arthritis
| Article | Year |
|---|---|
CD134 as target for specific drug delivery to auto-aggressive CD4+ T cells in adjuvant arthritis.
Topics: Animals; Arthritis, Experimental; Autoimmunity; CD4 Antigens; Cells, Cultured; Drug Delivery Systems | 2005 |